Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


An Open Label Study of the Effects of Ketamine on a Veteran Clinical Population With Major Depressive Disorder (MDD)


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03053830

Organisation Name: VA Connecticut Healthcare System

Overal Status: Active, not recruiting

Start Date: January 31, 2017

Last Update: October 6, 2020

Lead Sponsor: VA Connecticut Healthcare System

Brief Summary: Medically healthy Veterans ages 21-75 that have been diagnosed with Depression will get up to 6 treatments of Ketamine infusions, weekly. After treatment is completed, follow up will occur at 1 month, 3 months, and 6 months after completion of infusions to evaluate the longer term effects of ketamine.

Conditions:
  • Major Depressive Disorder


Total execution time in seconds: 0.2073118686676